Bile acid TUDCA improves insulin clearance by increasing the expression of insulin-degrading enzyme in the liver of obese mice

[1]  N. Casals,et al.  Reduction of Hypothalamic Endoplasmic Reticulum Stress Activates Browning of White Fat and Ameliorates Obesity , 2016, Diabetes.

[2]  A. Boschero,et al.  Acute exercise restores insulin clearance in diet-induced obese mice. , 2016, The Journal of endocrinology.

[3]  A. Boschero,et al.  The bile acid TUDCA increases glucose-induced insulin secretion via the cAMP/PKA pathway in pancreatic beta cells. , 2016, Metabolism: clinical and experimental.

[4]  W. Guo,et al.  Effects of Bariatric Surgery on Serum Bile Acid Composition and Conjugation in a Diabetic Rat Model , 2016, Obesity Surgery.

[5]  Jiali Liu,et al.  Glycolipid Metabolism Disorder in the Liver of Obese Mice Is Improved by TUDCA via the Restoration of Defective Hepatic Autophagy , 2015, International journal of endocrinology.

[6]  P. van Endert,et al.  Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice , 2015, Nature Communications.

[7]  David R. Liu,et al.  Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones , 2014, Nature.

[8]  Jianping Ye,et al.  Regulation of Insulin Degrading Enzyme Activity by Obesity-Associated Factors and Pioglitazone in Liver of Diet-Induced Obese Mice , 2014, PloS one.

[9]  Á. Glavic,et al.  The Drosophila insulin-degrading enzyme restricts growth by modulating the PI3K pathway in a cell-autonomous manner , 2014, Molecular biology of the cell.

[10]  M. Patti,et al.  Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin. , 2014, The Journal of clinical endocrinology and metabolism.

[11]  G. J. Santos,et al.  Cafeteria diet inhibits insulin clearance by reduced insulin-degrading enzyme expression and mRNA splicing. , 2013, The Journal of endocrinology.

[12]  A. Pfeiffer,et al.  Hepatic Insulin Clearance Is Closely Related to Metabolic Syndrome Components , 2013, Diabetes Care.

[13]  M. Saad,et al.  Insulin-Resistance-Associated Compensatory Mechanisms of Pancreatic Beta Cells: A Current Opinion , 2013, Front. Endocrinol..

[14]  J. Chiang.  Bile acid metabolism and signaling. , 2013, Comprehensive Physiology.

[15]  Jun Ren,et al.  Tauroursodeoxycholic Acid Mitigates High Fat Diet-Induced Cardiomyocyte Contractile and Intracellular Ca2+ Anomalies , 2013, PloS one.

[16]  J. Holst,et al.  Increased hepatic insulin clearance after Roux-en-Y gastric bypass. , 2013, The Journal of clinical endocrinology and metabolism.

[17]  C. Bouchard,et al.  Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. , 2012, The New England journal of medicine.

[18]  S. Spiegel,et al.  Conjugated bile acids activate the sphingosine‐1‐phosphate receptor 2 in primary rodent hepatocytes , 2012, Hepatology.

[19]  S. Jee,et al.  Impact of metabolic syndrome independent of insulin resistance on the development of cardiovascular disease. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[20]  G. Bifulco,et al.  The Bile Acid Receptor GPBAR-1 (TGR5) Modulates Integrity of Intestinal Barrier and Immune Response to Experimental Colitis , 2011, PloS one.

[21]  M. Leissring,et al.  Deletion of Insulin-Degrading Enzyme Elicits Antipodal, Age-Dependent Effects on Glucose and Insulin Tolerance , 2011, PloS one.

[22]  M. Patti,et al.  The chemical chaperones tauroursodeoxycholic and 4‐phenylbutyric acid accelerate thyroid hormone activation and energy expenditure , 2011, FEBS letters.

[23]  R. Dalle Grave,et al.  Cognitive-Behavioral Strategies to Increase the Adherence to Exercise in the Management of Obesity , 2010, Journal of obesity.

[24]  Jouhyun Jeon,et al.  Changes in Hepatic Gene Expression upon Oral Administration of Taurine-Conjugated Ursodeoxycholic Acid in ob/ob Mice , 2010, PloS one.

[25]  R. Figlin,et al.  Akt inhibitors in clinical development for the treatment of cancer , 2010, Expert opinion on investigational drugs.

[26]  J. Chiang,et al.  Transgenic expression of cholesterol 7α‐hydroxylase in the liver prevents high‐fat diet–induced obesity and insulin resistance in mice , 2010, Hepatology.

[27]  A. Vikram,et al.  S961, an insulin receptor antagonist causes hyperinsulinemia, insulin-resistance and depletion of energy stores in rats. , 2010, Biochemical and biophysical research communications.

[28]  K. Park,et al.  Tauroursodeoxycholate (TUDCA), chemical chaperone, enhances function of islets by reducing ER stress. , 2010, Biochemical and biophysical research communications.

[29]  S. Mudaliar,et al.  Pioglitazone: side effect and safety profile , 2010, Expert opinion on drug safety.

[30]  S. Fiorucci,et al.  Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders. , 2009, Trends in pharmacological sciences.

[31]  J. Holst,et al.  Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism , 2009, Obesity.

[32]  S. Wagenpfeil,et al.  Weight-dependent differential contribution of insulin secretion and clearance to hyperinsulinemia of obesity , 2009, Regulatory Peptides.

[33]  A. Kotronen,et al.  Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. , 2008, Gastroenterology.

[34]  R. Bergman,et al.  Metabolic syndrome, hyperinsulinemia, and cancer. , 2007, The American journal of clinical nutrition.

[35]  E. Yilmaz,et al.  Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes , 2006, Science.

[36]  B. Teter,et al.  Insulin-Degrading Enzyme as a Downstream Target of Insulin Receptor Signaling Cascade: Implications for Alzheimer's Disease Intervention , 2004, The Journal of Neuroscience.

[37]  P. Wilson,et al.  Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study. , 2003, Diabetes.

[38]  Matthew P. Frosch,et al.  Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  D. Selkoe,et al.  Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[40]  B. Yoffe,et al.  Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress–induced caspase‐12 activation , 2002, Hepatology.

[41]  M G McInnis,et al.  Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. , 2000, Science.

[42]  W. Duckworth,et al.  Degradation of Amylin by Insulin-degrading Enzyme* , 2000, The Journal of Biological Chemistry.

[43]  H. Luthman,et al.  Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats. , 2000, Human molecular genetics.

[44]  C. Bogardus,et al.  The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. , 1999, The Journal of clinical investigation.

[45]  W. Duckworth,et al.  Insulin degradation: progress and potential. , 1998, Endocrine reviews.

[46]  B. Lunenfeld,et al.  Hyperinsulinemia induces a reversible impairment in insulin receptor function leading to diabetes in the sand rat model of non-insulin-dependent diabetes mellitus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[47]  K. Alberti,et al.  The Short Insulin Tolerance Test for Determination of Insulin Sensitivity: A Comparison with the Euglycaemic Clamp , 1992, Diabetic medicine : a journal of the British Diabetic Association.

[48]  J. Gearhart,et al.  Hyperinsulinemia in transgenic mice carrying multiple copies of the human insulin gene. , 1989, Developmental genetics.

[49]  G. Turcatti,et al.  Insulin proteinase liberates from glucagon a fragment known to have enhanced activity against Ca2+ + Mg2+-dependent ATPase. , 1988, The Biochemical journal.

[50]  W. Duckworth,et al.  Insulin metabolism and degradation. , 1981, Endocrine reviews.